论文部分内容阅读
西双版纳州是本省抗氯喹恶性疟主要流行区之一,为寻求合理应用抗疟药物代替氯喹治疗恶性疟,我组于1983年9月在西双版纳州大勐龙医院,根据世界卫生组织1981年8月在吉隆坡召开抗药性疟疾会议的建议用法,对抗氯喹恶性疟流行区的恶性疟现症病人,使用法西达三片,Fansidar每片含周效磺胺500mg、乙胺嘧啶25mg和伯喹30mg(基质)单剂口服,儿童剂量按年龄递减。并仿照世界卫生组织体内抗性判断标准,共观察16例,结果其中12例服药后7天内疟原虫
Xishuangbanna Prefecture is one of the major epidemic areas of chloroquine-resistant falciparum in this province. In order to seek a rational application of antimalarial drug instead of chloroquine for the treatment of falciparum malaria, our group was founded in September, 1983 in Dameng Long Hospital of Xishuangbanna Prefecture. According to the World Health Organization Proposed Use of Resistant Malaria Conference in Kuala Lumpur to Combat Plasmodium falciparum, a Plasmodium falciparum-endemic area against chloroquine, with three tablets of fazidar, Fansidar each containing psoralens (500 mg), pyrimethamine 25 mg and primaquine 30 mg ) A single oral dose, children’s dose decreased by age. And modeled on the World Health Organization in vivo resistance criteria, a total of 16 cases were observed, the results of which 12 cases within 7 days after taking Plasmodium